Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Extensively Drug-Resistant Tuberculosis (XDR TB)

Fact Sheet
Extensively Drug-Resistant Tuberculosis (XDR TB)

This fact sheet describes general information regarding extensively drug-resistant TB.

Author:

CDC NCHHSTP Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, Division of Tuberculosis Elimination

Country of Origin:

United States

View Webpage

Related Materials

Tuberculosis Extremadamente Resistente (XDR)[Extensively Drug-Resistant Tuberculosis (XDR TB) ]

This fact sheet describes general information regarding extensively drug-resistant TB.

Fact Sheet

Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response

This new report on anti-tuberculosis (TB) drug resistance by the World Health Organization (WHO) updates “Anti-tuberculosis drug resistance in the world: Report No. 4” published by WHO in 2008. It summarizes the latest data and provides latest estimates of the global epidemic of multidrug and extensively drug-resistant tuberculosis (M/XDR-TB). For the first time, this report includes an assessment of the progress countries are making to diagnose and treat MDR-TB cases.

Report

Emergence of Extensively Drug Resistant Tuberculosis

Extensively drug-resistant tuberculosis (XDR TB) outbreaks have been reported in South Africa, and strains have been identified on 6 continents. Dr. Peter Cegielski, team leader for drug-resistant TB with the Division of Tuberculosis Elimination at CDC, comments on a multinational team's report on this emerging global public health threat.

Webpage

Global resources for the prevention,
management, and elimination of TB.